Factors affecting carbon dioxide laser treatment for oral precancer: A patient cohort study

Lasers in Surgery and Medicine

Volumn 41, Issue 1, 2009, Pages 17-25

  Hamadah, O ^a,b   Thomson, P J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

Author keywords

CO2 laser; Dysplasia; Follow up; Margins; Oral precancer; Risk factor

Indexed keywords

ADULT; ARTICLE; CARBON DIOXIDE LASER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; LASER SURGERY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH LESION; ORAL SURGERY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LASERS, GAS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM, RESIDUAL; PRECANCEROUS CONDITIONS; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 58449111509     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20733     Document Type: Article

References (35)

1. Reibel J. Prognosis of oral pre-malignant lesions: Significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003;14:47-62.
2. Greer RO. Pathology of malignant and premalignant oral epithelial lesions. Otolaryngol Clin North Am 2006;39:249-275, v.
3. Epstein JB, Gorsky M, Fischer D, Gupta A, Epstein M, Elad S. A survey of the current approaches to diagnosis and management of oral premalignant lesions. J Am Dent Assoc 2007;138:1555-1562, quiz 1614.
4. Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, Fukuda H. Development of squamous cell carcinoma from pre-existent oral leukoplakia: With respect to treatment modality. Int J Oral Maxillofac Surg 2001;30:49-53.
5. Thomson PJ, Wylie J. Interventional laser surgery: An effective surgical and diagnostic tool in oral precancer management. Int J Oral Maxillofac Surg 2002;31:145-153.
6. Silverman S, Jr., Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984;53:563-568.
7. Toma S, Benso S, Albanese E, Palumbo R, Cantoni E, Nicolo G, Mangiante P. Treatment of oral leukoplakia with beta-carotene. Oncology 1992;49:77-81.
8. Kaugars GE, Silverman S, Jr., Lovas JG, Thompson JS, Brandt RB, Singh VN. Use of antioxidant supplements in the treatment of human oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:5-14.
9. Lodi G, Porter S. Management of potentially malignant disorders: Evidence and critique. J Oral Pathol Med 2008;37:63-69.
10. 2 laser on an out-patient basis: A useful procedure for prevention and early detection of oral carcinomas. Tumori 1986;72:307-312.
11. 2 laser surgery of oral premalignant lesions. Int J Oral Maxillofac Surg 1986;15:19-24.
12. Gongloff RK, Samit AM, Greene GW, Jr., Inneo GF, Gage AA. Cryosurgical management of benign and dysplastic intraoral lesions. J Oral Surg 1980;38:671-676.
13. Flynn MB, White M, Tabah RJ. Use of carbon dioxide laser for the treatment of premalignant lesions of the oral mucosa. J Surg Oncol 1988;37:232-234.
14. Clayman L. Preneoplastic of the oral cavity. In: Clayman L, Kuo P, eds. Laser in Maxillofacial Surgery and Dentistry. New York: Thiema; 1997. 37-44.
15. Brennan M, Migliorati CA, Wray D, Al-Hashimi I, Axéll T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Nair R, Sasser H, Schifter M, Silverman (Sol) B, Thongprasom K, Thornhill M, Warnakulasuriya S, van der Waal I. Management of oral epithelial dysplasia: A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(Suppl. 19):e11-e12.
16. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev 2006;4:CD001829.
17. 2 laser surgery in patients with oral leukoplakia: A 25 year follow up. Oral Oncol 2005;41:31-37.
18. Ishii J, Fujita K, Munemoto S, Komori T. Management of oral leukoplakia by laser surgery: Relation between recurrence and malignant transformation and clinicopathological features. J Clin Laser Med Surg 2004;22:27-33.
19. 2 laser in the treatment of oral white patches: Outcomes and factors affecting recurrence. Int J Oral Maxillofac Surg 2005;34:396-400.
20. Roodenburg JL, Panders AK, Vermey A. Carbon dioxide laser surgery of oral leukoplakia. Oral Surg Oral Med Oral Pathol 1991;71:670-674.
21. Damm DD. Dysplastic leukoplakia. N Engl J Med 2004;350:2718-2719, author reply 2718-2719.
22. Stocker J, Thomson PJ, Hamadah O. Laser surgery in oral oncology - The Newcastle experience. Surg J Roy Coll Surg Edinburgh Ireland (Suppl) Surgeon 2005;3:S32-S33.
23. Ishii J, Fujita K, Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol 2003;39:759-769.
24. Thomson PJ, Hamadah O. Cancerisation within the oral cavity: The use of 'field mapping biopsies' in clinical management. Oral Oncol 2007;43:20-26.
25. Lippman SM, Hong WK. Molecular markers of the risk of oral cancer. N Engl J Med 2001;344:1323-1326.
26. Epstein JB, Zhang L, Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2002;68:617-621.
27. Zhang L, Poh CF, Lam WL, Epstein JB, Cheng X, Zhang X, Priddy R, Lovas J, Le ND, Rosin MP. Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: Molecular evidence of incomplete resection. Oral Oncol 2001;37:505-512.
28. Partridge M, Pateromichelakis S, Phillips E, Emilion G, Langdon J. Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma. Clin Cancer Res 2001;7:1860-1866.
29. Rickards L, Fox K, Roberts C, Fletcher L, Goddard E. Living in Britain "General Household Survey 2002" National Statistics: http://www.statistics.gov.uk/downloads/theme-compendia/lib2002.pdf; 2004.
30. Jaber MA, Porter SR, Gilthorpe MS, Bedi R, Scully C. Risk factors for oral epithelial dysplasia - The role of smoking and alcohol. Oral Oncol 1999;35:151-156.
31. Roosaar A, Yin L, Johansson AL, Sandborgh-Englund G, Nyren O, Axell T. A long-term follow-up study on the natural course of oral leukoplakia in a Swedish population-based sample. J Oral Pathol Med 2007;36:78-82.
32. van Oijen MG, Gilsing MM, Rijksen G, Hordijk GJ, Slootweg PJ. Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol 1998;34:297-303.
33. Hamadah O, Hepburn S, Thomson PJ. Effects of active non-smoking programmes on smoking behaviour in oral pre-cancer patients. Int J Oral Maxillofac Surg 2007;36:706-711.
34. Petti S, Scully C. Association between different alcoholic beverages and leukoplakia among non- to moderate-drinking adults: A matched case-control study. Eur J Cancer 2006;42:521-527.
35. Thomas G, Hashibe M, Jacob BJ, Ramadas K, Mathew B, Sankaranarayanan R, Zhang ZF. Risk factors for multiple oral premalignant lesions. Int J Cancer 2003;107:285-291.